Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 05, 2018 Filed Mar 13, 2018 22:22 UTC |
Godard AlainDirector
|
SaleCommon Stock | 10,000 | $19.00 | $190,000.00 |
DisclosureSEC source: 0001127602-18-011458 · form4.xml · nonDerivative · entry 2 Godard Alain · CIK 0001712102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,200 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2017. Read SEC document |
| March 05, 2018 Filed Mar 13, 2018 22:22 UTC |
Godard AlainDirector
|
Exercise / conversionCommon Stock | 10,000 | $3.59 | $35,875.00 |
DisclosureSEC source: 0001127602-18-011458 · form4.xml · nonDerivative · entry 1 Godard Alain · CIK 0001712102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,200 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 19:02 UTC |
Arbadji MichelDirector of Business Developme
|
Exercise / conversionStock Option (Right-to-Buy) · Derivative | 3,500 | $0.00 Strike: $3.59 | $0.00 |
DisclosureSEC source: 0001615594-18-000017 · primary_doc.xml · derivative · entry 3 Arbadji Michel · CIK 0001712089 · Director of Business Developme 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,000 Underlying: Common Stock · 3,500 shares Expires 2026-04-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 19:02 UTC |
Arbadji MichelDirector of Business Developme
|
SaleCommon Stock | 3,500 | $18.63 | $65,219.70 |
DisclosureSEC source: 0001615594-18-000017 · primary_doc.xml · nonDerivative · entry 2 Arbadji Michel · CIK 0001712089 · Director of Business Developme 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,400 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 17, 2017. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.05-18.82, inclusive. The reporting person undertakes to provide Calyxt, Inc., any security holder of Calyxt, Inc., or the staff of the SEC, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote (2) to this Form 4. Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 19:02 UTC |
Arbadji MichelDirector of Business Developme
|
Exercise / conversionCommon Stock | 3,500 | $3.59 | $12,557.30 |
DisclosureSEC source: 0001615594-18-000017 · primary_doc.xml · nonDerivative · entry 1 Arbadji Michel · CIK 0001712089 · Director of Business Developme 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,900 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 26, 2018 Filed Feb 28, 2018 22:45 UTC |
Godard AlainDirector
|
Exercise / conversionStock Option (Right-to-Buy) · Derivative | 10,000 | $0.00 Strike: $3.59 | $0.00 |
DisclosureSEC source: 0001615594-18-000016 · primary_doc.xml · derivative · entry 3 Godard Alain · CIK 0001712102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,300 Underlying: Common Stock · 10,000 shares Expires 2026-04-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 26, 2018 Filed Feb 28, 2018 22:45 UTC |
Godard AlainDirector
|
SaleCommon Stock | 10,000 | $19.03 | $190,262.00 |
DisclosureSEC source: 0001615594-18-000016 · primary_doc.xml · nonDerivative · entry 2 Godard Alain · CIK 0001712102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,200 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2017. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.00-19.46, inclusive. The reporting person undertakes to provide Calyxt, Inc., any security holder of Calyxt, Inc., or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. Read SEC document |
| February 26, 2018 Filed Feb 28, 2018 22:45 UTC |
Godard AlainDirector
|
Exercise / conversionCommon Stock | 10,000 | $35.59 | $355,878.00 |
DisclosureSEC source: 0001615594-18-000016 · primary_doc.xml · nonDerivative · entry 1 Godard Alain · CIK 0001712102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,200 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 22, 2018 Filed Feb 22, 2018 23:09 UTC |
Godard AlainDirector
|
SaleCommon Stock | 400 | $19.00 | $7,600.00 |
DisclosureSEC source: 0001615594-18-000015 · primary_doc.xml · nonDerivative · entry 7 Godard Alain · CIK 0001712102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,200 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2017. Read SEC document |
| February 21, 2018 Filed Feb 22, 2018 23:09 UTC |
Godard AlainDirector
|
Exercise / conversionStock Option (Right-to-Buy) · Derivative | 13,700 | $0.00 Strike: $3.59 | $0.00 |
DisclosureSEC source: 0001615594-18-000015 · primary_doc.xml · derivative · entry 9 Godard Alain · CIK 0001712102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,300 Underlying: Common Stock · 13,700 shares Expires 2026-04-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 21, 2018 Filed Feb 22, 2018 23:09 UTC |
Godard AlainDirector
|
SaleCommon Stock | 13,300 | $19.19 | $255,200.40 |
DisclosureSEC source: 0001615594-18-000015 · primary_doc.xml · nonDerivative · entry 6 Godard Alain · CIK 0001712102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,600 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2017. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.00-19.44, inclusive. Read SEC document |
| February 21, 2018 Filed Feb 22, 2018 23:09 UTC |
Godard AlainDirector
|
Exercise / conversionCommon Stock | 13,700 | $3.58 | $49,046.00 |
DisclosureSEC source: 0001615594-18-000015 · primary_doc.xml · nonDerivative · entry 5 Godard Alain · CIK 0001712102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,900 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 21, 2018 Filed Feb 22, 2018 22:53 UTC |
Sahoo ManojChief Commercial Officer
|
SaleCommon Stock | 4,900 | $19.13 | $93,729.65 |
DisclosureSEC source: 0001615594-18-000014 · primary_doc.xml · nonDerivative · entry 5 Sahoo Manoj · CIK 0001712226 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,220 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on November 21, 2017. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.00-19.41, inclusive. Read SEC document |
| February 21, 2018 Filed Feb 22, 2018 22:53 UTC |
Sahoo ManojChief Commercial Officer
|
SaleCommon Stock | 980 | $19.51 | $19,121.17 |
DisclosureSEC source: 0001615594-18-000014 · primary_doc.xml · nonDerivative · entry 4 Sahoo Manoj · CIK 0001712226 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,120 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on November 21, 2017. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.13-19.82, inclusive. Read SEC document |
| February 20, 2018 Filed Feb 22, 2018 23:09 UTC |
Godard AlainDirector
|
Exercise / conversionStock Option (Right-to-Buy) · Derivative | 6,125 | $0.00 Strike: $3.71 | $0.00 |
DisclosureSEC source: 0001615594-18-000015 · primary_doc.xml · derivative · entry 8 Godard Alain · CIK 0001712102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,125 shares Expires 2024-12-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 20, 2018 Filed Feb 22, 2018 23:09 UTC |
Godard AlainDirector
|
SaleCommon Stock | 600 | $21.90 | $13,140.48 |
DisclosureSEC source: 0001615594-18-000015 · primary_doc.xml · nonDerivative · entry 4 Godard Alain · CIK 0001712102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,200 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2017. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.84-21.94, inclusive. Read SEC document |
| February 20, 2018 Filed Feb 22, 2018 23:09 UTC |
Godard AlainDirector
|
SaleCommon Stock | 1,900 | $21.23 | $40,341.18 |
DisclosureSEC source: 0001615594-18-000015 · primary_doc.xml · nonDerivative · entry 3 Godard Alain · CIK 0001712102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,800 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2017. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.80-21.68, inclusive. Read SEC document |
| February 20, 2018 Filed Feb 22, 2018 23:09 UTC |
Godard AlainDirector
|
SaleCommon Stock | 3,625 | $20.23 | $73,322.15 |
DisclosureSEC source: 0001615594-18-000015 · primary_doc.xml · nonDerivative · entry 2 Godard Alain · CIK 0001712102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,700 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2017. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.77-20.76, inclusive. The reporting person undertakes to provide Calyxt, Inc., any security holder of Calyxt, Inc., or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2-5 to this Form 4. Read SEC document |
| February 20, 2018 Filed Feb 22, 2018 23:09 UTC |
Godard AlainDirector
|
Exercise / conversionCommon Stock | 6,125 | $3.71 | $22,723.75 |
DisclosureSEC source: 0001615594-18-000015 · primary_doc.xml · nonDerivative · entry 1 Godard Alain · CIK 0001712102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,325 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 20, 2018 Filed Feb 22, 2018 22:53 UTC |
Sahoo ManojChief Commercial Officer
|
SaleCommon Stock | 400 | $21.92 | $8,768.00 |
DisclosureSEC source: 0001615594-18-000014 · primary_doc.xml · nonDerivative · entry 3 Sahoo Manoj · CIK 0001712226 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,100 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on November 21, 2017. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.88-21.96, inclusive. Read SEC document |
| February 20, 2018 Filed Feb 22, 2018 22:53 UTC |
Sahoo ManojChief Commercial Officer
|
SaleCommon Stock | 1,646 | $21.20 | $34,900.30 |
DisclosureSEC source: 0001615594-18-000014 · primary_doc.xml · nonDerivative · entry 2 Sahoo Manoj · CIK 0001712226 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,500 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on November 21, 2017. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.80-21.68, inclusive. Read SEC document |
| February 20, 2018 Filed Feb 22, 2018 22:53 UTC |
Sahoo ManojChief Commercial Officer
|
SaleCommon Stock | 2,854 | $20.22 | $57,693.90 |
DisclosureSEC source: 0001615594-18-000014 · primary_doc.xml · nonDerivative · entry 1 Sahoo Manoj · CIK 0001712226 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,146 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on November 21, 2017. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.79-20.72, inclusive. The reporting person undertakes to provide Calyxt, Inc., any security holder of Calyxt, Inc., or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2-6 to this Form 4. Read SEC document |
| February 20, 2018 Filed Feb 22, 2018 22:39 UTC |
Corkal Bryan W.J.Chief Financial Officer
|
SaleCommon Stock | 3,611 | $21.46 | $77,503.25 |
DisclosureSEC source: 0001615594-18-000013 · primary_doc.xml · nonDerivative · entry 5 Corkal Bryan W.J. · CIK 0001712240 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,400 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2017. F6 · price: The price listed in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.10-22.00, inclusive. Read SEC document |
| February 20, 2018 Filed Feb 22, 2018 22:39 UTC |
Corkal Bryan W.J.Chief Financial Officer
|
SaleCommon Stock | 6,189 | $20.32 | $125,729.54 |
DisclosureSEC source: 0001615594-18-000013 · primary_doc.xml · nonDerivative · entry 4 Corkal Bryan W.J. · CIK 0001712240 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,011 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2017. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00-21.00, inclusive. Read SEC document |
| February 20, 2018 Filed Feb 22, 2018 22:39 UTC |
Corkal Bryan W.J.Chief Financial Officer
|
SaleCommon Stock | 1,100 | $21.88 | $24,064.48 |
DisclosureSEC source: 0001615594-18-000013 · primary_doc.xml · nonDerivative · entry 3 Corkal Bryan W.J. · CIK 0001712240 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,200 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2017. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.84-21.94, inclusive. Read SEC document |
| February 20, 2018 Filed Feb 22, 2018 22:39 UTC |
Corkal Bryan W.J.Chief Financial Officer
|
SaleCommon Stock | 3,000 | $21.19 | $63,584.70 |
DisclosureSEC source: 0001615594-18-000013 · primary_doc.xml · nonDerivative · entry 2 Corkal Bryan W.J. · CIK 0001712240 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,300 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2017. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.80-21.1949, inclusive. Read SEC document |
| February 20, 2018 Filed Feb 22, 2018 22:39 UTC |
Corkal Bryan W.J.Chief Financial Officer
|
SaleCommon Stock | 5,700 | $20.24 | $115,347.48 |
DisclosureSEC source: 0001615594-18-000013 · primary_doc.xml · nonDerivative · entry 1 Corkal Bryan W.J. · CIK 0001712240 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,300 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2017. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.77-20.76, inclusive. The reporting person undertakes to provide Calyxt, Inc., any security holder of Calyxt, Inc., or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2-6 to this Form 4. Read SEC document |
| July 25, 2017 Filed Jul 28, 2017 01:52 UTC |
Dumont PhilippeDirector
|
PurchaseCommon Stock | 400 | $8.00 | $3,200.00 |
DisclosureSEC source: 0000950103-17-007203 · dp78782_4-dumont.xml · nonDerivative · entry 2 Dumont Philippe · CIK 0001712186 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 F2 · shares: Represents purchase of shares in the Company's directed share program in connection with the Company's initial public offering. Read SEC document |
| June 14, 2017 Filed Jul 28, 2017 01:52 UTC |
Dumont PhilippeDirector
|
GrantStock Option (Right to buy) · Derivative | 29,400 | $0.00 Strike: $13.29 | $0.00 |
DisclosureSEC source: 0000950103-17-007203 · dp78782_4-dumont.xml · derivative · entry 3 Dumont Philippe · CIK 0001712186 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,400 Underlying: Common Stock · 29,400 shares Expires 2027-06-14 F3 · derivative.exercise_date: The stock option to purchase Company common stock vests 15% on the first anniversary of the grant date and 15% on the second anniversary of the grant date, with the remainder vesting quarterly in equal installments over the following 42 months. Read SEC document |
| June 14, 2017 Filed Jul 28, 2017 01:52 UTC |
Dumont PhilippeDirector
|
GrantRestricted Stock Unit | 19,600 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-17-007203 · dp78782_4-dumont.xml · nonDerivative · entry 1 Dumont Philippe · CIK 0001712186 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,600 F1 · shares: Restricted stock units with respect to Calyxt, Inc. (the "Company") common stock vest 15% on the first anniversary of the grant date and 15% on the second anniversary of the grant date, with the remainder vesting quarterly in equal installments over the following 42 months. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.